5,7-dihydroxytryptamine has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Culp, S; DeSouza, EB; Lehmann, J; Zaczek, R | 1 |
| Ricaurte, GA; Scheffel, U | 1 |
| Cabrera, T; Hamilton, ME; Hata, N; Lorens, SA | 1 |
| Hatzidimitriou, G; Markowska, AL; Olton, DS; Ricaurte, GA; Wenk, GL; Wlos, J | 1 |
| Dudley, MW; Kehne, JH; Ketteler, HJ; McCloskey, TC; Schmidt, CJ; Sullivan, CK | 1 |
| Callahan, BT; Cord, BJ; Ricaurte, GA | 1 |
| Baumann, MH; Rothman, RB; Wang, X; Xu, H | 1 |
| Baumann, MH; Morales, M; Rothman, RB; Wang, X; Xu, H | 1 |
| Hatzidimitriou, G; McCann, U; McLane, MW; Ricaurte, G; Tong, L; Xie, T; Yuan, J | 1 |
| Coolen, LM; Gudelsky, GA; Straiko, MM; Zemlan, FP | 1 |
| Bastos, ML; Capela, JP; Carvalho, F; Dirnagl, U; Lautenschlager, M; Meisel, A | 1 |
| Biezonski, DK; Meyer, JS | 1 |
| Bird, J; Bradbury, S; Colussi-Mas, J; Mueller, M; Ricaurte, G; Schenk, S | 1 |
13 other study(ies) available for 5,7-dihydroxytryptamine and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Atrophy; Brain; Cerebral Ventricles; Designer Drugs; Dopamine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Injections, Intraventricular; Male; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Organ Specificity; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Stereoisomerism | 1992 |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamine neurotoxicity: a presynaptic serotonergic positron emission tomography ligand?
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Ligands; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Synapses; Tomography, Emission-Computed; Tritium | 1990 |
Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Amphetamines; Animals; Arousal; Behavior, Animal; Brain; Designer Drugs; Dihydroxytryptamines; Fenfluramine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin | 1989 |
3,4-Methylenedioxymethamphetamine, serotonin and memory.
Topics: 3,4-Methylenedioxyamphetamine; 5,7-Dihydroxytryptamine; Animals; Brain Chemistry; Desipramine; Immunohistochemistry; Learning; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Scopolamine; Serotonin | 1993 |
Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Brain Chemistry; Clozapine; Dopamine Antagonists; Fluorobenzenes; Male; Methiothepin; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Presynaptic Terminals; Rats; Receptors, Neurotransmitter; Ritanserin; Serotonin; Serotonin Agents; Serotonin Antagonists; Stimulation, Chemical | 1996 |
Long-term impairment of anterograde axonal transport along fiber projections originating in the rostral raphe nuclei after treatment with fenfluramine or methylenedioxymethamphetamine.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Uptake Inhibitors; Animals; Axonal Transport; Axons; Desipramine; Fenfluramine; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; N-Methyl-3,4-methylenedioxyamphetamine; Neural Pathways; Neurotoxins; Pargyline; Proline; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Time Factors; Tritium | 2001 |
3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Animals; Astrocytes; Brain; Brain Chemistry; Carrier Proteins; Down-Regulation; Glial Fibrillary Acidic Protein; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Neurotoxins; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Up-Regulation | 2004 |
(+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
Topics: 5,7-Dihydroxytryptamine; Animals; Cell Membrane; Endosomes; Glial Fibrillary Acidic Protein; Heme Oxygenase (Decyclizing); Male; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neuroglia; Neurons; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2005 |
Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines.
Topics: 5,7-Dihydroxytryptamine; Animals; Axons; Brain; Down-Regulation; Fenfluramine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxins; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Wallerian Degeneration | 2006 |
The effect of amphetamine analogs on cleaved microtubule-associated protein-tau formation in the rat brain.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Animals; Brain Chemistry; Data Interpretation, Statistical; Dopamine; Glial Fibrillary Acidic Protein; Immunohistochemistry; Male; Methamphetamine; Microtubule-Associated Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; tau Proteins | 2007 |
5,7-Dihydroxitryptamine toxicity to serotonergic neurons in serum free raphe cultures.
Topics: 5,7-Dihydroxytryptamine; Animals; Cells, Cultured; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Fluoxetine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Degeneration; Nerve Fibers; Raphe Nuclei; Rats | 2008 |
Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Benzylamines; Brain; Central Nervous System Stimulants; Disease Models, Animal; Female; Gene Expression; Hallucinogens; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Neurotransmitter Uptake Inhibitors; Pregnancy; Protein Binding; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins; Synaptosomes; Time Factors; Vesicular Monoamine Transport Proteins | 2010 |
Acquisition of MDMA self-administration: pharmacokinetic factors and MDMA-induced serotonin release.
Topics: 5,7-Dihydroxytryptamine; Animals; Area Under Curve; Cocaine; Conditioning, Operant; Dopamine; Dopamine Uptake Inhibitors; Infusions, Intravenous; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats, Sprague-Dawley; Self Administration; Serotonin; Serotonin Agents | 2014 |